UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (14), p.2455-2456

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-02, Vol.388 (6), p.489-498

2023

Volltextzugriff (PDF)

KRAS Mutation: Should We Test for It, and Does It Matter?

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1112-1121

2013

Volltextzugriff (PDF)

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1387-1394

2017

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

Nanomedicine (London, England), 2007-08, Vol.2 (4), p.415-423

Stinchcombe, Thomas E

2007

Volltextzugriff (PDF)

Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4769-4777

2010

Volltextzugriff (PDF)

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Clinical cancer research, 2019-10, Vol.25 (19), p.5832-5842

2019

Volltextzugriff (PDF)

Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR -Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4076-4085

2020

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2063-2069

2012

Volltextzugriff (PDF)

Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer

Radiotherapy and oncology, 2017-11, Vol.125 (2), p.293-300

2017

Volltextzugriff (PDF)

Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations

Clinical cancer research, 2012-09, Vol.18 (17), p.4775-4784

2012

Volltextzugriff (PDF)

Clinicopathologic Features of Advanced Squamous NSCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1411-1422

2016

Volltextzugriff (PDF)

Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3679-3681

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer

Current treatment options in oncology, 2016-04, Vol.17 (4), p.18-18, Article 18

Stinchcombe, Thomas E.

2016

Volltextzugriff (PDF)

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (15), p.2671-2672

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Pemetrexed and Cisplatin in Mesothelioma

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2123-2124

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

High Incidence of Cetuximab-Related Infusion Reactions in Tennessee and North Carolina and the Association With Atopic History

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3644-3648

2007

Volltextzugriff (PDF)

Limited‐Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms

The oncologist (Dayton, Ohio), 2010-02, Vol.15 (2), p.187-195

2010

Volltextzugriff (PDF)

Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2867-2868

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Novel agents in development for advanced non-small cell lung cancer

Therapeutic Advances in Medical Oncology, 2014-09, Vol.6 (5), p.240-253

Stinchcombe, Thomas E.

2014

Volltextzugriff (PDF)

Encorafenib and Binimetinib: A New Treatment Option for BRAF V600E -Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3679-3681

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC

Journal of clinical oncology, 2023-05, Vol.41 (13), p.2303-2304

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1159-1160

Stinchcombe, Thomas E

2023

Volltextzugriff (PDF)

Considerations for Second‐Line Therapy of Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2008-01, Vol.13 (S1), p.28-36

2008

Volltextzugriff (PDF)

Recent advances in the treatment of non-small cell and small cell lung cancer

F1000 prime reports, 2014-12, Vol.6, p.117-117

Stinchcombe, Thomas E

2014

Volltextzugriff (PDF)

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Englisch
(227)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(164)
Oncology
(151)
Humans
(141)
Lung Neoplasms - Drug Therapy
(79)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(69)
Male
(62)
Female
(60)
Lung Neoplasms - Pathology
(53)
Aged
(52)
Neoplasm Staging
(50)
Carcinoma, Non-Small-Cell Lung - Pathology
(48)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(46)
Middle Aged
(46)
Respiratory System
(45)
Lung Cancer
(35)
Adult
(34)
Chemotherapy
(30)
Aged, 80 And Over
(29)
Treatment Outcome
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Flashback Foreword: Cisplatin/Pemetrexed in Non-Small-Cell Lung Cancer

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

KRAS Mutation: Should We Test for It, and Does It Matter?

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR -Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer

Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations

Clinicopathologic Features of Advanced Squamous NSCLC

Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non-Small-Cell Lung Cancer

The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer

Flashback Foreword: Pemetrexed and Cisplatin in Mesothelioma

High Incidence of Cetuximab-Related Infusion Reactions in Tennessee and North Carolina and the Association With Atopic History

Limited‐Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms

Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer

Novel agents in development for advanced non-small cell lung cancer

Encorafenib and Binimetinib: A New Treatment Option for BRAF V600E -Mutant Non-Small-Cell Lung Cancer

Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC

Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial

Considerations for Second‐Line Therapy of Non‐Small Cell Lung Cancer

Recent advances in the treatment of non-small cell and small cell lung cancer

Suchergebnisse filtern